Go to
JCI Insight
Citations to this article
Manish Sagar, … , Laura F. White, Joseph P. Mizgerd
Published September 30, 2020
Citation Information: J Clin Invest. 2021;131(1):e143380. https://doi.org/10.1172/JCI143380.
Citation Information: J Clin Invest. 2021;131(1):e143380. https://doi.org/10.1172/JCI143380.
Abstract
Four different endemic coronaviruses (eCoVs) are etiologic agents for the seasonal common cold, and these eCoVs share extensive sequence homology with human SARS coronavirus 2 (SARS-CoV-2). Here, we show that individuals with, as compared with those without, a recent documented infection with eCoV were tested at greater frequency for respiratory infections but had a similar rate of SARS-CoV-2 acquisition. Importantly, the patients with a previously detected eCoV had less-severe coronavirus disease 2019 (COVID-19) illness. Our observations suggest that preexisting immune responses against endemic human coronaviruses can mitigate disease manifestations from SARS-CoV-2 infection.
Authors
Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura F. White, Joseph P. Mizgerd
Citation information
Citations to this article (249)
| Title and authors | Publication | Year |
|---|---|---|
|
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models
Naghibosadat M, Babuadze GG, Pei Y, Hurst J, Salvant E, Gaete K, Biondi M, Moloo B, Goldstein A, Avery S, Ma K, Pietraszek A, Wootton SK, Alhaboub A, Martin B, Mubareka S, Corredor J, Sultana A, Adeekoa A, Budylowski P, Ostrowski M, Chao J, Nagy E, Kozak R |
Journal of Virology | 2025 |
|
Epidemiology, Clinical Significance, and Diagnosis of Respiratory Viruses and Their Co-Infections in the Post-COVID Era
Contes KM, Liu BM |
Pathogens | 2025 |
|
Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity
Florian DM, Bauer M, Popovitsch A, Fae I, Springer DN, Graninger M, Traugott M, Weseslindtner L, Aberle SW, Fischer G, Kundi M, Stiasny K, Zoufaly A, Landry SJ, Aberle JH |
Frontiers in Immunology | 2025 |
|
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination
Karl V, Hofmann M, Thimme R |
Journal of Virology | 2025 |
|
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care.
Breznik JA, Cowbrough B, Bilaver L, Dushoff M, Stacey HD, Ang J, Clare R, Kennedy A, Costa AP, Nazy I, Loeb M, Verschoor CP, Bramson J, Miller MS, Bowdish DME |
Open forum infectious diseases | 2025 |
|
Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4(+) T Cells.
Kim AR, Koh JY, Rha MS, Jung JH, Ko JH, Choi HK, Jeon JH, Seok H, Park DW, Peck KR, Choi JY, Park SH, Choi WS, Jeong HW, Shin EC |
Immune network | 2025 |
|
Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines
Adhikari B, Oltz EM, Gumina RJ, Kick MK, Saif LJ, Vlasova AN |
Vaccines | 2025 |
|
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection
Weigl N, Pleimelding C, Gilberg L, Huynh D, Brand I, Bruger J, Frese J, Eser TM, Ahmed MI, Guggenbuehl-Noller JM, Stirner R, Hoelscher M, Pritsch M, Geldmacher C, Kobold S, Roider J |
PLOS One | 2025 |
|
Development of a cross-protective common cold coronavirus vaccine
Dangi T, Li S, Penaloza-MacMaster P |
bioRxiv | 2025 |
|
Unbiased immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies
Juan H-Vazquez, Paloma Cal-Sabater, Elisa Arribas-Rodríguez, Aida Fiz-López, Candido Perez-Segurado, Álvaro Martín-Muñoz, Ángel Prado, Marina Perez Mazzali, Carolina González-de Castro, Alejandro del Hierro González, Ignacio Graciani, Sonia González, Sara Gutiérrez, Pablo Tellería, Cristina Novoa, Silvia Rojo-Rello, Antonio Garcia-Blesa, Rosa Sedano, Ana García, Sonsoles Garcinuño Perez, Marta Domínguez-Gil, Cristina García, Mª Guerra, Eduardo Muñoz-Sánchez, Cristina Barragan-Pérez, Soraya Morales, Oriana Casazza-Donnarumma, Daniel Ramos Pollo, Natalia Santamarta-Solla, Paula Mª Álvarez-Manzanares, Sara Bravo, Cristina García-Alonso, Jenifer Gay-Alonso, José A Garrote, Eduardo Arranz, José Mª Eiros, Fernando Rescalvo-Santiago, Carolina Quevedo-Villegas, Eduardo Tamayo, Antonio Orduña, Carlos Dueñas, María Jesús Peñarrubia, Sara Cuesta-Sancho, María Montoya, David Bernardo |
Frontiers in immunology | 2024 |
|
Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
David Bean, Janet Monroe, YanMei Liang, Ella Borberg, Yasmeen Senussi, Zoe Swank, Sujata Chalise, David Walt, Janice Weinberg, Manish Sagar |
Science Translational Medicine | 2024 |
|
Human coronavirus OC43-elicited CD4(+) T cells protect against SARS-CoV-2 in HLA transgenic mice.
Dos Santos Alves RP, Timis J, Miller R, Valentine K, Pinto PBA, Gonzalez A, Regla-Nava JA, Maule E, Nguyen MN, Shafee N, Landeras-Bueno S, Olmedillas E, Laffey B, Dobaczewska K, Mikulski Z, McArdle S, Leist SR, Kim K, Baric RS, Ollmann Saphire E, Elong Ngono A, Shresta S |
Nature Communications | 2024 |
|
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV
Ng\u2019uni TL, Musale V, Nkosi T, Mandolo J, Mvula M, Michelo C, Karim F, Moosa MY, Khan K, Jambo KC, Hanekom W, Sigal A, Kilembe W, Ndhlovu ZM |
Frontiers in immunology | 2024 |
|
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
Abela IA, Schwarzmüller M, Ulyte A, Radtke T, Haile SR, Ammann P, Raineri A, Rueegg S, Epp S, Berger C, Böni J, Manrique A, Audigé A, Huber M, Schreiber PW, Scheier T, Fehr J, Weber J, Rusert P, Günthard HF, Kouyos RD, Puhan MA, Kriemler S, Trkola A, Pasin C |
mBio | 2024 |
|
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Collins CP, Longo DL, Murphy WJ |
Frontiers in immunology | 2024 |
|
The Influence of Cross-Reactive T Cells in COVID-19
Eggenhuizen PJ, Ooi JD |
Biomedicines | 2024 |
|
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients
Lidenge SJ, Yalcin D, Bennett SJ, Ngalamika O, Kweyamba BB, Mwita CJ, Tso FY, Mwaiselage J, West JT, Wood C |
Viruses | 2024 |
|
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
Stanley AM, Aksyuk AA, Wilkins D, Green JA, Lan D, Shoemaker K, Tieu HV, Sobieszczyk ME, Falsey AR, Kelly EJ |
Frontiers in immunology | 2024 |
|
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals
Adami FL, de Castro MV, Almeida BD, Daher IP, Yamamoto MM, Souza Santos K, Zatz M, Naslavsky MS, Rosa DS, Cunha-Neto E, de Oliveira VL, Kalil J, Boscardin SB |
Frontiers in immunology | 2024 |
|
Does Prior Respiratory Viral Infection Provide Cross-Protection Against Subsequent Respiratory Viral Infections? A Systematic Review and Meta-Analysis
Gopal V, Koh MC, Ngiam JN, Hang-Cheng O, Somani J, Tambyah PA, Tey J |
Viruses | 2024 |
|
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools
Binder RA, Matta AM, Forconi CS, Oduor CI, Bedekar P, Patrone PN, Kearsley AJ, Odwar B, Batista J, Forrester SN, Leftwich HK, Cavacini LA, Moormann AM |
PloS one | 2024 |
|
Global Epidemiology and Seasonality of Human Seasonal Coronaviruses: A Systematic Review
Wilson R, Kovacs D, Crosby M, Ho A |
Open Forum Infectious Diseases | 2024 |
|
SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study
Hanssen DA, Arts K, Nix WH, Sweelssen NN, Welbers TT, de Theije C, Wieten L, Pagen DM, Brinkhues S, Penders J, Dukers-Muijrers NH, Hoebe CJ, Savelkoul PH, van Loo IH |
Microbiology spectrum | 2024 |
|
Epidemiology of Human Seasonal Coronaviruses Among People With Mild and Severe Acute Respiratory Illness in Blantyre, Malawi, 2011–2017
Kovacs D, Mambule I, Read JM, Kiran A, Chilombe M, Bvumbwe T, Aston S, Menyere M, Masina M, Kamzati M, Ganiza TN, Iuliano D, McMorrow M, Bar-Zeev N, Everett D, French N, Ho A |
The Journal of Infectious Diseases | 2024 |
|
Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19?
Şanlidağ Işbilen G, Uysal AA, Yiğit S, Appak Ö, Sipahi H, Bozdayi G, Sayiner A, Çiçek C, Güzel Tunçcan Ö, Sipahi OR |
Turkish journal of medical sciences | 2024 |
|
High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
Joseph JO, Ylade M, Daag JV, Aogo R, Crisostomo MV, Mpingabo P, Premkumar L, Deen J, Katzelnick LC |
BMC Infectious Diseases | 2024 |
|
A Serological Multiplexed Immunoassay (MIA) Detects Antibody Reactivity to SARS-CoV-2 and Other Viral Pathogens in Liberia and Is Configurable as a Multiplexed Inhibition Test (MINT).
Haun BK, To A, Williams CA, Ball A, Fong K, Wong TAS, Shobayo B, Teahton J, Ching L, Kamara V, Tekah DM, Humphrey P, Berestecky J, Nerurkar VR, Lehrer AT |
Immuno | 2024 |
|
HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia.
Lesmes-Rodríguez LC, Pedraza-Castillo LN, Jaramillo-Hernández DA |
Biomedica : revista del Instituto Nacional de Salud | 2024 |
|
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.
Notarbartolo S |
Vaccines | 2024 |
|
Recent Endemic Coronavirus Infection Associates With Higher SARS-CoV-2 Cross-Reactive Fc Receptor Binding Antibodies
Bean DJ, Liang YM, Sagar M |
bioRxiv | 2024 |
|
Sex differences in pneumonia risk during COVID-19 in Mexico
Venegas-Ramírez J, Mendoza-Cano O, Trujillo X, Huerta M, Ríos-Silva M, Lugo-Radillo A, Bricio-Barrios JA, Cuevas-Arellano HB, Uribe-Ramos JM, Solano-Barajas R, García-Solórzano LA, Camacho-delaCruz AA, Murillo-Zamora E |
Scientific Reports | 2024 |
|
Differential patterns of antibody response against SARS-CoV-2 nucleocapsid epitopes detected in sera from patients in the acute phase of COVID-19, convalescents, and pre-pandemic individuals
Razim A, Pacyga-Prus K, Kazana-Płuszka W, Zabłocka A, Macała J, Ciepłucha H, Gamian A, Górska S |
Pathogens and Disease | 2024 |
|
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron
Pinto PB, Timis J, Chuensirikulchai K, Li QH, Lu HH, Maule E, Nguyen M, Alves RP, Verma SK, Ana-Sosa-Batiz F, Valentine K, Landeras-Bueno S, Kim K, Hastie K, Saphire EO, Alves A, Elong Ngono A, Shresta S |
NPJ Vaccines | 2024 |
|
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
Schmidt A, Casadei N, Brand F, Demidov G, Vojgani E, Abolhassani A, Aldisi R, Butler-Laporte G, Alawathurage TM, Augustin M, Bals R, Bellinghausen C, Berger MM, Bitzer M, Bode C, Boos J, Brenner T, Cornely OA, Eggermann T, Erber J, Feldt T, Fuchsberger C, Gagneur J, Göpel S, Haack T, Häberle H, Hanses F, Heggemann J, Hehr U, Hellmuth JC, Herr C, Hinney A, Hoffmann P, Illig T, Jensen BE, Keitel V, Kim-Hellmuth S, Koehler P, Kurth I, Lanz AL, Latz E, Lehmann C, Luedde T, Maj C, Mian M, Miller A, Muenchhoff M, Pink I, Protzer U, Rohn H, Rybniker J, Scaggiante F, Schaffeldt A, Scherer C, Schieck M, Schmidt SV, Schommers P, Spinner CD, Vehreschild MJ, Velavan TP, Volland S, Wilfling S, Winter C, Richards JB, Heimbach A, Becker K, Ossowski S, Schultze JL, Nürnberg P, Nöthen MM, Motameny S, Nothnagel M, Riess O, Schulte EC, Ludwig KU |
PLOS Pathogens | 2024 |
|
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues
Kenney D, O\u2019Connell AK, Tseng AE, Turcinovic J, Sheehan ML, Nitido AD, Montanaro P, Gertje HP, Ericsson M, Connor JH, Vrbanac V, Crossland NA, Harly C, Balazs AB, Douam F |
bioRxiv | 2024 |
|
Targets of influenza human T-cell response are mostly conserved in H5N1
Sidney J, Kim AR, de Vries RD, Peters B, Meade PS, Krammer F, Grifoni A, Sette A |
mBio | 2024 |
|
Highly networked SARS-CoV-2 peptides elicit T cell responses with enhanced specificity
Gabriel Duette, Eunok Lee, Gabriela Martins Costa Gomes, Katie Tungatt, Chloe Doyle, Vicki Stylianou, Ashley Lee, Susan Maddocks, Janette Taylor, Rajiv Khanna, Kerrie Sandgren, Anthony Cunningham, Sarah Palmer |
ImmunoHorizons | 2023 |
|
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
G Fedele, G Russo, I Schiavoni, P Leone, E Olivetta, V Perri, MA Zingaropoli, MR Ciardi, P Pasculli, CM Mastroianni, P Stefanelli |
Diagnostic Microbiology and Infectious Disease | 2023 |
|
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla L, Müller V |
Viruses | 2023 |
|
Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A |
2023 | |
|
Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2.
Huang X, Liang C, Li M, Chen H, Li Z, Ruan Q, Hu X, Zeng L, Lin H, Zhao W, Xiao J, Sun L, Sun J |
Human vaccines | 2023 |
|
Current tobacco use and COVID-19 diagnoses in a cohort of adult clients of public dental clinics in Sweden.
Galanti MR, Andersson F, Caspersen IH, Peña S, Karvonen S, Magnus P, Raffetti E, Orsini N, Magnusson C, Shaaban AN, Hergens MP, Skott P |
Scientific Reports | 2023 |
|
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Soni M, Migliori E, Fu J, Assal A, Chan HT, Pan J, Khatiwada P, Ciubotariu R, May MS, Pereira M, De Giorgi V, Sykes M, Mapara MY, Muranski P |
2023 | |
|
Defending against SARS-CoV-2: The T cell perspective
Almendro-Vázquez P, Laguna-Goya R, Paz-Artal E |
Frontiers in immunology | 2023 |
|
High proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses
Namuniina A, Muyanja ES, Biribawa VM, Okech BA, Ssemaganda A, Price MA, Hills N, Nanteza A, Bagaya BS, Weiskopf D, Riou C, Reynolds SJ, Galwango RM, Redd AD |
2023 | |
|
Peptide microarray IgM and IgG screening of pre-SARS-CoV-2 human serum samples from Zimbabwe for reactivity with peptides from all seven human coronaviruses: a cross-sectional study
Ashworth J, Mathie D, Scott F, Mahendran Y, Woolhouse M, Stoevesandt O, Mduluza T, Mutapi F |
2023 | |
|
Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2
Liu D, Chen C, Chen D, Zhu A, Li F, Zhuang Z, Mok CK, Dai J, Li X, Jin Y, Chen Z, Sun J, Wang Y, Li Y, Zhang Y, Wen L, Zhang Z, Zhuo J, Wang J, Ran W, Wang D, Zhang S, Tang Y, Li S, Lai X, Wei P, Yuan J, Chen F, Huang S, Sun F, Qian Z, Tan W, Zhao J, Peiris M, Zhao J |
Proceedings of the National Academy of Sciences | 2023 |
|
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
Karaba AH, Johnston TS, Beck E, Laeyendecker O, Cox AL, Klein SL, Sullivan DJ |
mBio | 2023 |
|
The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps
Wong A, Barrero Guevara LA, Goult E, Briga M, Kramer SC, Kovacevic A, Opatowski L, Domenech de Cellès M |
PLoS pathogens | 2023 |
|
Association between the Seroprevalence of Antibodies against Seasonal Alphacoronaviruses and SARS-CoV-2 Humoral Immune Response, COVID-19 Severity, and Influenza Vaccination
Brydak L, Sikora D, Poniedziałek B, Hallmann E, Szymański K, Kondratiuk K, Rzymski P |
Journal of Clinical Medicine | 2023 |
|
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults
Taraz Samandari, Joshua Ongalo, Kim McCarthy, Richard Biegon, Philister Madiega, Anne Mithika, Joseph Orinda, Grace Mboya, Patrick Mwaura, Omu Anzala, Clayton Onyango, Fredrick Oluoch, Eric Osoro, Charles-Antoine Dutertre, Nicole Tan, Shou Hang, Smrithi Hariharaputran, David Lye, Amy Herman-Roloff, Nina Bert, Antonio Bertoletti |
Journal of Clinical Investigation | 2023 |
|
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
Casado JL, Vizcarra P, Martín-Hondarza A, Blasco M, Grandal-Platero M, Haemmerle J, Fernández-Escribano M, Vallejo A |
Viruses | 2023 |
|
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months.
Serwanga J, Ankunda V, Sembera J, Kato L, Oluka GK, Baine C, Odoch G, Kayiwa J, Auma BO, Jjuuko M, Nsereko C, Cotten M, Onyachi N, Muwanga M, Lutalo T, Fox J, Musenero M, Kaleebu P |
Frontiers in immunology | 2023 |
|
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study.
Lawal BJ, Gallagher KE, Kitonsa J, Tindanbil D, Kasonia K, Drammeh A, Lowe B, Mukadi-Bamuleka D, Patterson C, Greenwood B, Samai M, Leigh B, Tetteh KKA, Ruzagira E, Watson-Jones D, Kavunga-Membo H |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023 |
|
Viral persistence, reactivation, and mechanisms of long COVID.
Chen B, Julg B, Mohandas S, Bradfute SB |
eLife | 2023 |
|
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
Norton NJ, Holder KA, Ings DP, Harnum DO, Russell RS, Grant MD |
Viruses | 2023 |
|
Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants.
Shamabadi NS, Bagasra AB, Pawar S, Bagasra O |
The Libyan journal of medicine | 2023 |
|
Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study.
Oh TK, Kim S, Song IA |
Journal of Intensive Care | 2023 |
|
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen J, Fan J, Zhao Y, Jiang D, Niu Z, Zhang Z, Cao G |
Frontiers in immunology | 2023 |
|
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers.
Kolehmainen P, Huttunen M, Iakubovskaia A, Maljanen S, Tauriainen S, Yatkin E, Pasternack A, Naves R, Toivonen L, Tähtinen PA, Ivaska L, Lempainen J, Peltola V, Waris M, Kakkola L, Ritvos O, Julkunen I |
Scientific Reports | 2023 |
|
Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies
Devaux CA, Fantini J |
Pathogens | 2023 |
|
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A |
Cell reports. Medicine | 2023 |
|
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity
Benede NS, Tincho MB, Walters A, Subbiah V, Ngomti A, Baguma R, Butters C, Mennen M, Skelem S, Adriaanse M, van Graan S, Balla SR, Moyo-Gwete T, Moore PL, Botha M, Workman L, Zar HJ, Ntusi NA, Zühlke L, Webb K, Riou C, Burgers WA, Keeton RS |
2023 | |
|
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets
Nowill AE, Caruso M, de Campos-Lima PO |
Frontiers in immunology | 2023 |
|
Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration.
Abdelaziz MO, Raftery MJ, Weihs J, Bielawski O, Edel R, Köppke J, Vladimirova D, Adler JM, Firsching T, Voß A, Gruber AD, Hummel LV, Fernandez Munoz I, Müller-Marquardt F, Willimsky G, Elleboudy NS, Trimpert J, Schönrich G |
Frontiers in immunology | 2023 |
|
An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination.
da Silva Antunes R, Grifoni A, Frazier A, Weiskopf D, Sette A |
International Immunology | 2023 |
|
Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study
Namuniina A, Muyanja ES, Biribawa VM, Okech BA, Ssemaganda A, Price MA, Hills N, Nanteza A, Bagaya BS, Weiskopf D, Riou C, Reynolds SJ, Galiwango RM, Redd AD |
2023 | |
|
Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells
Kanis FM, Meier JP, Guldan H, Niller HH, Dahm M, Dansard A, Zander T, Struck F, Soutschek E, Deml L, Möbus S, Barabas S |
Diagnostics | 2023 |
|
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.
Pérez-Alós L, Hansen CB, Almagro Armenteros JJ, Madsen JR, Heftdal LD, Hasselbalch RB, Pries-Heje MM, Bayarri-Olmos R, Jarlhelt I, Hamm SR, Møller DL, Sørensen E, Ostrowski SR, Frikke-Schmidt R, Hilsted LM, Bundgaard H, Nielsen SD, Iversen KK, Garred P |
Nature Communications | 2023 |
|
Multicenter analysis of epidemiological and clinical features of pediatric acute lower respiratory tract infections associated with common human coronaviruses in China, 2014–2019
Han S, Xu B, Feng Q, Feng Z, Zhu Y, Ai J, Deng L, Li C, Cao L, Sun Y, Fu Z, Jin R, Shang Y, Chen Z, Xu L, Xie Z, Shen K |
Virology Journal | 2023 |
|
The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
Soni MK, Migliori E, Fu J, Assal A, Chan HT, Pan J, Khatiwada P, Ciubotariu R, May MS, Pereira MR, De Giorgi V, Sykes M, Mapara MY, Muranski PJ |
Frontiers in immunology | 2023 |
|
Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo
Mitangala PN, Irenge LM, Musubao ET, Kahindo JB, Ayonga PN, Kyembwa Safari I, Kubuya JB, Ntabe EN, Kabangwa Senga RK, Mutombo GN, Ambroise J, Gala JL |
Epidemiology and Infection | 2023 |
|
T cell immune memory after covid-19 and vaccination
Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, Klenerman P, Payne RP |
2023 | |
|
Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
Bean DJ, Monroe J, Liang YM, Borberg E, Senussi Y, Swank Z, Chalise S, Walt D, Weinberg J, Sagar M |
2023 | |
|
Immune imprinting and next-generation coronavirus vaccines.
Huang CQ, Vishwanath S, Carnell GW, Chan ACY, Heeney JL |
Nature Microbiology | 2023 |
|
High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines
Joseph JO, Ylade M, Daag JV, Aogo R, Crisostomo MV, Mpingabo P, Premkumar L, Deen J, Katzelnick L |
Research square | 2023 |
|
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Ratcliffe H, Tiley KS, Longet S, Tonry C, Roarty C, Watson C, Amirthalingam G, Vichos I, Morey E, Douglas NL, Marinou S, Plested E, Aley PK, Galiza E, Faust SN, Hughes S, Murray C, Roderick MR, Shackley F, Oddie S, Lee TW, Turner DP, Raman M, Owens S, Turner PJ, Cockerill H, Lopez Bernal J, Ijaz S, Poh J, Shute J, Linley E, Borrow R, Hoschler K, Brown KE, Carroll MW, Klenerman P, Dunachie SJ, Ramsay M, Voysey M, Waterfield T, Snape MD |
iScience | 2023 |
|
Antiviral Potential of Azelastine against Major Respiratory Viruses
Fischhuber K, Bánki Z, Kimpel J, Kragl N, Rössler A, Bolze A, Muellauer B, Angerer J, Nagy G, Nagy E, Szijarto V |
Viruses | 2023 |
|
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations
Shaprova ON, Shanshin DV, Kolosova EA, Borisevich SS, Soroka AA, Merkuleva IA, Nikitin AO, Volosnikova EA, Ushkalenko ND, Zaykovskaya AV, Pyankov OV, Elchaninova SA, Shcherbakov DN, Ilyicheva TN |
Antibodies | 2023 |
|
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms.
Cankat S, Demael MU, Swadling L |
Cellular & molecular immunology | 2023 |
|
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.
Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Srivatsan S, Shadick NA, Rao DA, Kellman B, Mann CJ, Lauffenburger D, Wallace ZS, Sparks JA, Alter G |
Science Translational Medicine | 2023 |
|
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity
Benede N, Tincho MB, Walters A, Subbiah V, Ngomti A, Baguma R, Butters C, Hahnle L, Mennen M, Skelem S, Adriaanse M, Facey-Thomas H, Scott C, Day J, Spracklen TF, van Graan S, Balla SR, Moyo-Gwete T, Moore PL, MacGinty R, Botha M, Workman L, Johnson M, Goldblatt D, Zar HJ, Ntusi NA, Zühlke L, Webb K, Riou C, Burgers WA, Keeton RS |
iScience | 2023 |
|
CD4+ T-cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses.
Bezawit A. Woldemeskel, Arbor G Dykema, Caroline Garliss, Saphira Cherfils, Kellie N Smith, Joel Blankson |
Journal of Clinical Investigation | 2022 |
|
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components
Lichen Jing, Xia Wu, Maxwell P. Krist, Tien-Ying Hsiang, Victoria Campbell, Christopher McClurkan, Sydney Favors, Lawrence Hemingway, Charmie Godornes, Denise Q Tong, Stacy Selke, Angela LeClair, Chul-Woo Pyo, Daniel E. Geraghty, Kerry J. Laing, Anna Wald, Michael Gale, Jr., David Koelle |
JCI Insight | 2022 |
|
SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses
J Lawrenz, Q Xie, F Zech, T Weil, A Seidel, D Krnavek, L van der Hoek, J Münch, J Müller, F Kirchhoff |
Clinical Infectious Diseases | 2022 |
|
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
K Hagemann, K Riecken, J Jung, H Hildebrandt, S Menzel, M Bunders, B Fehse, F KochNolte, F Heinrich, S Peine, J zur Wiesch, T Brehm, M Addo, M Lütgehetmann, M Altfeld |
European Journal of Immunology | 2022 |
|
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin |
Frontiers in immunology | 2022 |
|
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
A Crowley, H Natarajan, A Hederman, C Bobak, J Weiner, W Wieland-Alter, J Lee, E Bloch, A Tobian, A Redd, J Blankson, D Wolf, T Goetghebuer, A Marchant, R Connor, P Wright, M Ackerman |
eLife | 2022 |
|
Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning
L Morsink, J van Doesum, G Choi, C Hazenberg, A Biswana, F Meppelink, L Bungener, A Lambeck, G Huls |
Blood Cancer Journal | 2022 |
|
Robust and durable serological response following pediatric SARS-CoV-2 infection
H Renk, A Dulovic, A Seidel, M Becker, D Fabricius, M Zernickel, D Junker, R Groß, J Müller, A Hilger, S Bode, L Fritsch, P Frieh, A Haddad, T Görne, J Remppis, T Ganzemueller, A Dietz, D Huzly, H Hengel, K Kaier, S Weber, E Jacobsen, P Kaiser, B Traenkle, U Rothbauer, M Stich, B Tönshoff, G Hoffmann, B Müller, C Ludwig, B Jahrsdörfer, H Schrezenmeier, A Peter, S Hörber, T Iftner, J Münch, T Stamminger, H Groß, M Wolkewitz, C Engel, W Liu, M Rizzi, B Hahn, P Henneke, A Franz, K Debatin, N Schneiderhan-Marra, A Janda, R Elling |
Nature Communications | 2022 |
|
Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
K Sim, G Ko, S Bae, K Choi, J Lee, B Kim, K Lee, M Song, S Park |
Frontiers in immunology | 2022 |
|
Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
G Nasrallah |
EBioMedicine | 2022 |
|
The T cell immune response against SARS-CoV-2
P Moss |
Nature Immunology | 2022 |
|
SARS-CoV-2 infections in children: Understanding diverse outcomes
P Brodin |
Immunity | 2022 |
|
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
H Park, M Park, J Seok, J You, J Kim, J Kim, M Park |
The Journal of Microbiology | 2022 |
|
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
M Ercanoglu, L Gieselmann, S Dähling, N Poopalasingam, S Detmer, M Koch, M Korenkov, S Halwe, M Klüver, V Cristanziano, H Janicki, M Schlotz, J Worczinski, B Gathof, H Gruell, M Zehner, S Becker, K Vanshylla, C Kreer, F Klein |
iScience | 2022 |
|
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
A Tomic, D Skelly, A Ogbe, D OConnor, M Pace, E Adland, F Alexander, M Ali, K Allott, M Ansari, S Belij-Rammerstorfer, S Bibi, L Blackwell, A Brown, H Brown, B Cavell, E Clutterbuck, T de Silva, D Eyre, S Lumley, A Flaxman, J Grist, C Hackstein, R Halkerston, A Harding, J Hill, T James, C Jay, S Johnson, B Kronsteiner, Y Lie, A Linder, S Longet, S Marinou, P Matthews, J Mellors, C Petropoulos, P Rongkard, C Sedik, L Silva-Reyes, H Smith, L Stockdale, S Taylor, S Thomas, T Tipoe, L Turtle, V Vieira, T Wrin, L Stafford, H Abuelgasim, A Alhussni, C Arancibia-Cárcamo, M Borak, J Cutteridge, A Deeks, L Denly, S Dimitriadis, S Fassih, T Foord, T Fordwoh, J Holmes, B Horsington, S Kerneis, D Kim, K Lillie, J Morrow, D ODonnell, T Ritter, B Simmons, A Taylor, S Thomas, Y Warren, A Watson, E Weeks, R Wilson, R Young, C Duncan, S Moore, R Payne, A Richter, S Rowland-Jones, A Mentzer, M Cassar, T Dong, A Fries, J Gilbert-Jaramillo, L Ho, J Knight, S Neubauer, Y Peng, N Petousi, B Raman, N Talbot, A Pollard, T Lambe, C Conlon, K Jeffery, S Travis, P Goulder, J Frater, A Mentzer, L Stafford, M Carroll, W James, P Klenerman, E Barnes, C Dold, S Dunachie |
Nature Communications | 2022 |
|
Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
G Tanunliong, A Liu, S Kaweski, M Irvine, R Reyes, D Purych, M Krajden, M Morshed, I Sekirov, S Gantt, D Skowronski, A Jassem |
Frontiers in immunology | 2022 |
|
Epidemiology and Clinical Characteristics of Human Coronaviruses-Associated Infections in Children: A Multi-Center Study
K Jo, S Choi, C Oh, H Kim, B Choi, D Jo, S Park |
Frontiers in Pediatrics | 2022 |
|
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
E Garanina, S Hamza, R Stott-Marshall, E Martynova, M Markelova, Y Davidyuk, V Shakirova, N Kaushal, M Baranwal, I Khaertynova, A Rizvanov, T Foster, S Khaiboullina |
Frontiers in microbiology | 2022 |
|
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Bhattacharya D |
Immunity | 2022 |
|
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito R, Augello M, Ben-Haim A, Bono V, d\u2019Arminio Monforte A, Marchetti G |
Frontiers in immunology | 2022 |
|
The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19
Saghafi N, Rezaee SA, Momtazi-Borojeni AA, Tavasolian F, Sathyapalan T, Abdollahi E, Sahebkar A |
Life Sciences | 2022 |
|
Mecanismos del COVID-19 en el cuerpo humano: Lo que sabemos hasta ahora
Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S |
2022 | |
|
Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection.
Pence S, Caykara B, Pence HH, Tekin S, Keskin BC, Uncu AT, Uncu AO, Ozturk E |
Northern Clinics of Istanbul | 2022 |
|
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
Becerra-Artiles A, Calvo-Calle JM, Co MD, Nanaware PP, Cruz J, Weaver GC, Lu L, Forconi C, Finberg RW, Moormann AM, Stern LJ |
Cell Reports | 2022 |
|
The past, current and future epidemiological dynamic of SARS-CoV-2
Balloux F, Tan C, Swadling L, Richard D, Jenner C, Maini M, van Dorp L |
2022 | |
|
Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic
Yu ED, Narowski TM, Wang E, Garrigan E, Mateus J, Frazier A, Weiskopf D, Grifoni A, Premkumar L, da Silva Antunes R, Sette A |
Cell Host & Microbe | 2022 |
|
The immunopathogenesis of SARS‐CoV‐2 infection in children: diagnostics, treatment and prevention
Patel H, McArdle A, Seaby E, Levin M, Whittaker E |
IBMS BoneKEy | 2022 |
|
Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
de Oliveira-Filho EF, de Carvalho OV, Carneiro IO, Fernandes FD, Vaz SN, Pedroso C, Gonzalez-Auza L, Urbieta VC, Kühne A, Mayoral R, Jo WK, Moreira-Soto A, Reusken CB, Drosten C, Brites C, Osterrieder K, Netto EM, Ristow LE, Maia RD, Vogel FS, de Almeida NR, Franke CR, Drexler JF |
Frontiers in immunology | 2022 |
|
Cross‐reactive cellular, but not humoral, immunity is detected between OC43 and SARS‐CoV‐2 NPs in people not infected with SARS‐CoV‐2: Possible role of cTFH cells
García\u2010Jiménez ÁF, Cáceres\u2010Martell Y, Fernández\u2010Soto D, Martínez Fleta P, Casasnovas JM, Sánchez\u2010Madrid F, Frade JM, Valés\u2010Gómez M, Reyburn HT |
Journal of leukocyte biology | 2022 |
|
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Moga E, Lynton-Pons E, Domingo P |
Frontiers in immunology | 2022 |
|
Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.
Goldblatt D, Alter G, Crotty S, Plotkin SA |
Immunological Reviews | 2022 |
|
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE |
Immunological Reviews | 2022 |
|
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
Cugno M, Meroni PL, Consonni D, Griffini S, Grovetti E, Novembrino C, Torri A, Griffante G, Gariglio M, Varani L, Peyvandi F |
Microorganisms | 2022 |
|
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.
Sette A, Crotty S |
Immunological Reviews | 2022 |
|
Human seasonal coronavirus neutralization and COVID‐19 severity
Wells DA, Cantoni D, Mayora\u2010Neto M, Genova CD, Sampson A, Ferrari M, Carnell G, Nadesalingam A, Smith P, Chan A, Raddi G, Castillo\u2010Olivares J, Baxendale H, Temperton N, Heeney JL |
Journal of Medical Virology | 2022 |
|
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Guo Y, Han J, Zhang Y, He J, Yu W, Zhang X, Wu J, Zhang S, Kong Y, Guo Y, Lin Y, Zhang J |
Frontiers in immunology | 2022 |
|
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
Shafqat A, Arabi TZ, Sabbah BN, Abdulkader HS, Shafqat S, Razak A, Kashir J, Alkattan K, Yaqinuddin A |
Human vaccines | 2022 |
|
Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron
Gerges D, Kapps S, Hernández-Carralero E, Freire R, Aiad M, Schmidt S, Winnicki W, Reiter T, Pajenda S, Schmidt A, Sunder-Plassmann G, Wagner L |
Viruses | 2022 |
|
Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
Yamashita T, Shimakami T, Nio K, Terashima T, Okajima M, Taniguchi T, Wada T, Honda M, Gabata T, Ota K, Yanagihara K, Kaneko S |
Journal of Clinical Medicine | 2022 |
|
T-cell responses to SARS-CoV-2 in unexposed South African women
Nunes MC, Johnson MJ, Kwatra G, Weinberg A, Madhi SA |
2022 | |
|
Phytochemical Discrimination, Biological Activity and Molecular Docking of Water-Soluble Inhibitors from Saussurea costus Herb against Main Protease of SARS-CoV-2
Idriss H, Siddig B, Maldonado PG, Elkhair HM, Alakhras AI, Abdallah EM, Torres PH, Elzupir AO |
Molecules (Basel, Switzerland) | 2022 |
|
T-cell responses to SARS-CoV-2 in unexposed South African women.
Nunes MC, Johnson MJ, Kwatra G, Weinberg A, Madhi SA |
2022 | |
|
Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Dan J, da Silva Antunes R, Grifoni A, Weiskopf D, Crotty S, Sette A |
Clinical Infectious Diseases | 2022 |
|
Risk of severe COVID-19 infection among adults with prior exposure to children
Solomon MD, Escobar GJ, Lu Y, Schlessinger D, Steinman JB, Steinman L, Lee C, Liu VX |
Proceedings of the National Academy of Sciences | 2022 |
|
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Bertoletti A, Le Bert N, Tan AT |
Immunity | 2022 |
|
T cells in SARS-CoV-2 infection and vaccination
Young A |
2022 | |
|
Pre-existing humoral immunity to LPH-CoVs exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
Nina Li, XueYun Li, Jiani Wu, Shengze Zhang, Lin Zhu, Qiqi Chen, Ying Fan, Zhengyu Wu, Sidian Xie, Qi Chen, Ning Wang, Nan Wu, Chuming Luo, Yuelong Shu, Huanle Luo |
Frontiers in immunology | 2022 |
|
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
Bertoletti A, Le Bert N, Tan AT |
International journal of molecular sciences | 2022 |
|
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
Lavell AH, Sikkens JJ, Edridge AW, van der Straten K, Sechan F, Oomen M, Buis DT, Schinkel M, Burger JA, Poniman M, van Rijswijk J, de Jong MD, de Bree GJ, Peters EJ, Smulders YM, Sanders RW, van Gils MJ, van der Hoek L, Bomers MK |
iScience | 2022 |
|
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Wei X, Rong N, Liu J |
Frontiers in immunology | 2022 |
|
The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
Sridhar S, Chicz RM, Warren W, Tartaglia J, Savarino S, Gurunathan S, Toussaint JF |
Nature Communications | 2022 |
|
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals
Jaago M, Rähni A, Pupina N, Pihlak A, Sadam H, Tuvikene J, Avarlaid A, Planken A, Planken M, Haring L, Vasar E, Baćević M, Lambert F, Kalso E, Pussinen P, Tienari PJ, Vaheri A, Lindholm D, Timmusk T, Ghaemmaghami AM, Palm K |
Scientific Reports | 2022 |
|
The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic
Agrati C, Carsetti R, Bordoni V, Sacchi A, Quintarelli C, Locatelli F, Ippolito G, Capobianchi MR |
Immunology | 2022 |
|
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
Lim JM, Hang SK, Hariharaputran S, Chia A, Tan N, Lee ES, Chng E, Lim PL, Young BE, Lye DC, Le Bert N, Bertoletti A, Tan AT |
Cell reports. Medicine | 2022 |
|
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Shadick NA, Laffenburger D, Wallace ZS, Sparks JA, Alter G |
2022 | |
|
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
Ruiz MJ, Siracusano G, Cottignies-Calamarte A, Tudor D, Real F, Zhu A, Pastori C, Capron C, Rosenberg AR, Temperton N, Cantoni D, Liao H, Ternette N, Moine P, Godement M, Geri G, Chiche JD, Annane D, Cramer Bordé E, Lopalco L, Bomsel M |
Frontiers in immunology | 2022 |
|
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, Gouma S, Manzoni TB, Hicks P, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, Brock A, Weaver J, Millar JS, DerOhannessian S, Greenplate AR, Frank I, Rader DJ, Wherry EJ, Bates P, Hensley SE |
Cell Reports | 2022 |
|
Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination
Salgado Del Riego E, Saiz ML, Corte-Iglesias V, Leoz Gordillo B, Martin-Martin C, Rodríguez-Pérez M, Escudero D, Lopez-Larrea C, Suarez-Alvarez B |
Frontiers in immunology | 2022 |
|
Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes
Bhattacharya J, Magness P, Kulldorff M |
Advances in Biological Regulation | 2022 |
|
A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4+ T lymphocytes in unexposed individuals
Li J, Reinke S, Shen Y, Schollmeyer L, Liu YC, Wang Z, Hardt S, Hipfl C, Hoffmann U, Frischbutter S, Chang HD, Alexander T, Perka C, Radbruch H, Qin Z, Radbruch A, Dong J |
Frontiers in immunology | 2022 |
|
Immune response induced by novel coronavirus infection
Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
Fujii SI, Yamasaki S, Iyoda T, Shimizu K |
Ensho Saisei | 2022 |
|
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.
Bartsch YC, Chen JW, Kang J, Burns MD, St Denis KJ, Sheehan ML, Davis JP, Edlow AG, Balazs AB, Yonker LM, Alter G |
npj Vaccines | 2022 |
|
SARS-CoV-2 epitopes inform future vaccination strategies
Shafqat A, Omer MH, Ahmad O, Niaz M, Abdulkader HS, Shafqat S, Mushtaq AH, Shaik A, Elshaer AN, Kashir J, Alkattan K, Yaqinuddin A |
Frontiers in immunology | 2022 |
|
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, Ogbe A |
Nature reviews. Immunology | 2022 |
|
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19
Khoo WH, Jackson K, Phetsouphanh C, Zaunders JJ, Alquicira-Hernandez J, Yazar S, Ruiz-Diaz S, Singh M, Dhenni R, Kyaw W, Tea F, Merheb V, Lee FX, Burrell R, Howard-Jones A, Koirala A, Zhou L, Yuksel A, Catchpoole DR, Lai CL, Vitagliano TL, Rouet R, Christ D, Tang B, West NP, George S, Gerrard J, Croucher PI, Kelleher AD, Goodnow CG, Sprent JD, Powell JE, Brilot F, Nanan R, Hsu PS, Deenick EK, Britton PN, Phan TG |
Clinical Immunology | 2022 |
|
Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China
Luo Y, Lv H, Zhao S, Sun Y, Liu C, Chen C, Liang W, Kwok KO, Teo QW, So RT, Lin Y, Deng Y, Li B, Dai Z, Zhu J, Zhang D, Fernando J, Wu NC, Tun HM, Bruzzone R, Mok CK, Mu X |
International Journal of Infectious Diseases | 2022 |
|
Inducing broad-based immunity against viruses with pandemic potential
Sette A, Saphire EO |
Immunity | 2022 |
|
Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period
Yu ED, Narowski TM, Wang E, Garrigan E, Mateus J, Frazier A, Weiskopf D, Grifoni A, Premkumar L, da Silva Antunes R, Sette A |
2022 | |
|
Does common cold coronavirus infection protect against severe SARS-CoV2 disease?
David K. Meyerholz, Stanley Perlman |
Journal of Clinical Investigation | 2021 |
|
Family matters for coronavirus disease and vaccines
Manish Sagar |
Journal of Clinical Investigation | 2021 |
|
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel Monaco, Athena Chen, Kirsten Littlefield, Evan Bloch, Eric Fujimura, Ingo Ruczinski, Andrew Crowley, Harini Natarajan, Savannah Butler, Joshua Weiner, Mamie Li, Tania Bonny, Sarah Benner, Ashwin Balagopal, David Sullivan, Shmuel Shoham, Thomas Quinn, Susan Eshleman, Arturo Casadevall, Andrew Redd, Oliver Laeyendecker, Margaret Ackerman, Andrew Pekosz, Steve Elledge, Matthew Robinson, Aaron Tobian, H. Larman |
Journal of Clinical Investigation | 2021 |
|
Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline Garliss, Laurene S Cheung, Dilshad Choudhury, Jiajia Zhang, Luis Aparicio, Sadhana Bom, Rufiaat Rashid, Justina X. Caushi, Emily Han-Chung Hsiue, Katherine Cascino, Elizabeth A Thompson, Abena K. Kwaa, Dipika Singh, Sampriti Thapa, Alvaro A. Ordonez, Andrew Pekosz, Franco D'Alessio, Jonathan D. Powell, Srinivasan Yegnasubramanian, Shibin Zhou, Drew Pardoll, Hongkai Ji, Andrea Cox, Joel N Blankson, Kellie N Smith |
Journal of Clinical Investigation | 2021 |
|
Lung resident memory B cells protect against bacterial pneumonia
Kimberly A. Barker, Neelou S. Etesami, Anukul T. Shenoy, Emad I. Arafa, Carolina Lyon De Ana, Nicole Smith, Ian Martin, Wesley N Goltry, Alexander M.S. Barron, Jeffrey L. Browning, Hasmeena Kathuria, Anna C. Belkina, Antoine Guillon, Xuemei Zhong, Nicholas A Crossland, Matthew Jones, Lee J. Quinton, Joseph P. Mizgerd |
Journal of Clinical Investigation | 2021 |
|
Cross-protective immunity following coronavirus vaccination and coronavirus infection
Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Mincheol Park, Jake Class, Lavanya Visvabharathy, Thomas Ciucci, Igor Koralnik, Justin M Richner, Pablo Penaloza-MacMaster |
Journal of Clinical Investigation | 2021 |
|
A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2
Abdelilah Majdoubi, Christina Michalski, Sarah O’Connell, Sarah Dada, Sandeep R Narpala, Jean P Gelinas, Disha Mehta, Claire Cheung, Dirk F.H. Winkler, Manjula Basappa, Aaron C Liu, Matthias Görges, Vilte E Barakauskas, Michael A Irvine, Jennifer Mehalko, Dominic Esposito, Inna Sekirov, Agatha Jassem, David M Goldfarb, Steven Pelech, Daniel C. Douek, Adrian B McDermott, Pascal M Lavoie |
JCI Insight | 2021 |
|
Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration
Sigrid Gouma, Madison E Weirick, Marcus J Bolton, Claudia P. Arevalo, Eileen Goodwin, Elizabeth M. Anderson, Christopher M. McAllister, Shannon R Christensen, Debora Dunbar, Danielle Fiore, Amanda Brock, JoEllen Weaver, John S. Millar, Stephanie DerOhannessian, Ian Frank, Daniel Rader, E. John Wherry, Scott E. Hensley |
JCI Insight | 2021 |
|
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
CT Deakin, GH Cornish, KW Ng, N Faulkner, W Bolland, J Hope, A Rosa, R Harvey, S Hussain, C Earl, BR Jebson, MG Wilkinson, LR Marshall, K OBrien, EC Rosser, A Radziszewska, H Peckham, H Patel, J Heaney, H Rickman, S Paraskevopoulou, CF Houlihan, MJ Spyer, SJ Gamblin, J McCauley, E Nastouli, M Levin, P Cherepanov, C Ciurtin, LR Wedderburn, G Kassiotis |
The American Journal of Medicine | 2021 |
|
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
S Winklmeier, K Eisenhut, D Taskin, H Rübsamen, R Gerhards, C Schneider, PR Wratil, M Stern, P Eichhorn, OT Keppler, M Klein, S Mader, T Kümpfel, E Meinl |
iScience | 2021 |
|
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, RA Booth, Y Durocher, M Cuperlovic-Culf, SA Bennett, AM Crawley, PM Giguère, C Cooper, MA Langlois |
EBioMedicine | 2021 |
|
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies
C Dobaño, R Santano, A Jiménez, M Vidal, J Chi, NR Melero, M Popovic, R López-Aladid, L Fernández-Barat, M Tortajada, F Carmona-Torre, G Reina, A Torres, A Mayor, C Carolis, AL García-Basteiro, R Aguilar, G Moncunill, L Izquierdo |
Translational research : the journal of laboratory and clinical medicine | 2021 |
|
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
M Dugas, T Grote-Westrick, R Vollenberg, E Lorentzen, T Brix, H Schmidt, PR Tepasse, J Kühn |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
T cell immunity to SARS-CoV-2
J Niessl, T Sekine, M Buggert |
Seminars in Immunology | 2021 |
|
Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
ML Angelis, F Francescangeli, R Rossi, A Giuliani, RD Maria, A Zeuner |
Viruses | 2021 |
|
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
M Grobben, K van der Straten, PJ Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, B Appelman, AH Lavell, LA van Vught, JA Burger, M Poniman, M Oomen, D Eggink, TP Bijl, HD van Willigen, E Wynberg, BJ Verkaik, OJ Figaroa, PJ de Vries, TM Boertien, MK Bomers, JJ Sikkens, RL Grand, MD de Jong, M Prins, AW Chung, GJ de Bree, RW Sanders, MJ van Gils |
eLife | 2021 |
|
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers
R da Silva Antunes, S Pallikkuth, E Williams, ED Yu, J Mateus, L Quiambao, E Wang, SA Rawlings, D Stadlbauer, K Jiang, F Amanat, D Arnold, D Andrews, I Fuego, JM Dan, A Grifoni, D Weiskopf, F Krammer, S Crotty, ME Hoffer, SG Pahwa, A Sette |
The Journal of Infectious Diseases | 2021 |
|
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
L Guo, Y Wang, L Kang, Y Hu, L Wang, J Zhong, H Chen, L Ren, X Gu, G Wang, C Wang, X Dong, C Wu, L Han, Y Wang, G Fan, X Zou, H Li, J Xu, Q Jin, B Cao, J Wang |
Emerging Microbes & Infections | 2021 |
|
Adaptive immunity to human coronaviruses is widespread but low in magnitude
HX Tan, WS Lee, KM Wragg, C Nelson, R Esterbauer, HG Kelly, T Amarasena, R Jones, G Starkey, BZ Wang, O Yoshino, T Tiang, ML Grayson, H Opdam, R D'Costa, A Vago, LK Mackay, CL Gordon, AK Wheatley, SJ Kent, JA Juno, G Przybylowski, D Pritchard, R Moore, R Balakas, C Asmus, R Batac |
IBMS BoneKEy | 2021 |
|
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
SE Butler, AR Crowley, H Natarajan, S Xu, JA Weiner, CA Bobak, DE Mattox, J Lee, W Wieland-Alter, RI Connor, PF Wright, ME Ackerman |
Frontiers in immunology | 2021 |
|
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
|
Adaptive immunity to SARS-CoV-2 and COVID-19
A Sette, S Crotty |
Cell | 2021 |
|
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
MS Rha, AR Kim, EC Shin |
Immune Network | 2021 |
|
Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
MK Jung, EC Shin |
Molecules and Cells | 2021 |
|
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients
M Anft, A Blazquez-Navarro, U Stervbo, S Skrzypczyk, O Witzke, R Wirth, M Choi, C Hugo, P Reinke, TL Meister, E Steinmann, S Pfaender, P Schenker, R Viebahn, TH Westhoff, N Babel |
Journal of Nephrology | 2021 |
|
Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms
MA Cappel, JA Cappel, DA Wetter |
Mayo Clinic Proceedings | 2021 |
|
Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection
P Zimmermann, N Curtis |
The Pediatric Infectious Disease Journal | 2021 |
|
Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses
JM Dijkstra, AP Frenette, B Dixon |
F1000Research | 2021 |
|
Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
K Muthumani, Z Xu, M Jeong, JN Maslow, VS Kalyanaraman, A Srinivasan |
Translational Medicine Communications | 2021 |
|
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study
RE Sealy, JL Hurwitz |
Microorganisms | 2021 |
|
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals
A Johansson, U Malhotra, Y Kim, R Gomez, M Krist, A Wald, D Koelle, W Kwok, A Sant |
PLoS pathogens | 2021 |
|
An evaluation of patients with a previous endemic coronavirus infection during the COVID‐19 pandemic
B Otlu, Y Yakupogullari, ES Tanriverdi, Y Bayindir |
Journal of Medical Virology | 2021 |
|
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection
M Soni, E Migliori, A Assal, HT Chan, R Ciubotariu, JB Pan, K Cicero, M Pereira, MY Mapara, P Muranski |
Cytotherapy | 2021 |
|
A comprehensive review on efficient approaches for combating coronaviruses
M Pouresmaieli, E Ekrami, A Akbari, N Noorbakhsh, NB Moghadam, M Mamoudifard |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
|
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19
A Sharma, K Kontodimas, M Bosmann |
Frontiers in Medicine | 2021 |
|
Do Islanders Have a More Reactive Behavioral Immune System? Social Cognitions and Preferred Interpersonal Distances During the COVID-19 Pandemic
I Hromatko, A Grus, G Kolđeraj |
Frontiers in psychology | 2021 |
|
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
SA Lapp, VV Edara, A Lu, L Lai, L Hussaini, A Chahroudi, LJ Anderson, MS Suthar, EJ Anderson, CA Rostad, VC Huber |
PloS one | 2021 |
|
Comparable endemic coronavirus nucleoprotein‐specific antibodies in mild and severe Covid‐19 patients
S Leach, AM Harandi, T Bergström, LM Andersson, S Nilsson, L Hoek, M Gisslén |
Journal of Medical Virology | 2021 |
|
Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
O Guzmán-Martínez, K Guardado, M Varela-Cardoso, A Trujillo-Rivera, I Gómez-Ñañez, MC Ortiz-León, R Espinosa, C Ramos, JI Pérez-Carreón, DV López-Guerrero, CL Sampieri, AB Alanís-García, F Rojas-Durán, R Zenteno-Cuevas, M Gutiérrez, H Montero |
International journal of environmental research and public health | 2021 |
|
Neglected roles of IgG Fc-binding protein secreted from airway mucin-producing cells in protecting against SARS-CoV-2 infection
K Kobayashi, M Tachibana, Y Tsutsumi |
Innate immunity | 2021 |
|
Vaccines beyond antibodies: Spurred by pandemic research, are T‐cell vaccines moving closer to reality?
A King |
EMBO reports | 2021 |
|
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
A Grifoni, J Sidney, R Vita, B Peters, S Crotty, D Weiskopf, A Sette |
Cell Host & Microbe | 2021 |
|
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
EM Anderson, EC Goodwin, A Verma, CP Arevalo, MJ Bolton, ME Weirick, S Gouma, CM McAllister, SR Christensen, JE Weaver, P Hicks, TB Manzoni, O Oniyide, H Ramage, D Mathew, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, C Alanio, K DAndrea, O Kuthuru, J Dougherty, A Pattekar, J Kim, N Han, SA Apostolidis, AC Huang, LA Vella, L Kuri-Cervantes, MB Pampena, MR Betts, EJ Wherry, NJ Meyer, S Cherry, P Bates, DJ Rader, SE Hensley |
Cell | 2021 |
|
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
BM Jackson-Thompson, E Goguet, ED Laing, CH Olsen, S Pollett, KM Hollis-Perry, SE Maiolatesi, L Illinik, KF Ramsey, AE Reyes, Y Alcorta, MA Wong, J Davies, O Ortega, E Parmelee, AR Lindrose, M Moser, E Graydon, AG Letizia, CA Duplessis, A Ganesan, KP Pratt, AM Malloy, DW Scott, SK Anderson, AL Snow, CL Dalgard, JH Powers, D Tribble, TH Burgess, CC Broder, E Mitre |
BMC Infectious Diseases | 2021 |
|
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
U Greenbaum, K Klein, F Martinez, J Song, PF Thall, JL Ramdial, C Knape, FM Aung, J Scroggins, A Knopfelmacher, V Mulanovich, J Borjan, J Adachi, M Muthu, C Leung, MC Medina, R Champlin, A Olson, A Alousi, K Rezvani, EJ Shpall |
Frontiers in immunology | 2021 |
|
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”
LY García, AA Cerda |
Applied Health Economics and Health Policy | 2021 |
|
Isolation of Antibodies Against the Spike Protein of SARS-CoV from Pig Serum for Competitive Immunoassay
J Jung, JH Bong, TH Kim, JS Sung, C Lee, MJ Kang, HO Kim, HJ Shin, JC Pyun |
BioChip Journal | 2021 |
|
Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
SA Lynch, K Subbarao, S Mahanty, BE Barber, EV Roulis, L van der Hoek, JS McCarthy, KM Spann |
Viruses | 2021 |
|
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples
K Shrwani, R Sharma, M Krishnan, T Jones, M Mayora-Neto, D Cantoni, NJ Temperton, SL Dobson, K Subramaniam, PS McNamara, NA Cunliffe, L Turtle, Q Zhang |
The Journal of Infectious Diseases | 2021 |
|
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
J Mateus, JM Dan, Z Zhang, CR Moderbacher, M Lammers, B Goodwin, A Sette, S Crotty, D Weiskopf |
Science | 2021 |
|
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
N Ortega, M Ribes, M Vidal, R Rubio, R Aguilar, S Williams, D Barrios, S Alonso, P Hernández-Luis, RA Mitchell, C Jairoce, A Cruz, A Jimenez, R Santano, S Méndez, M Lamoglia, N Rosell, A Llupià, L Puyol, J Chi, NR Melero, D Parras, P Serra, E Pradenas, B Trinité, J Blanco, A Mayor, S Barroso, P Varela, A Vilella, A Trilla, P Santamaria, C Carolis, M Tortajada, L Izquierdo, A Angulo, P Engel, AL García-Basteiro, G Moncunill, C Dobaño |
Nature Communications | 2021 |
|
Severe asthma in the era of COVID-19: A narrative review
J Gaspar-Marques, M van Zeller, P Carreiro-Martins, CC Loureiro |
2021 | |
|
The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality?
J Adams, MJ MacKenzie, AK Amegah, A Ezeh, MA Gadanya, A Omigbodun, AM Sarki, P Thistle, AK Ziraba, S Stranges, M Silverman |
2021 | |
|
Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers
TG Egwang, TJ Owalla, E Okurut, G Apungia, A Fox, CD Carlo, RL Powell |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic
NC Marshall, RM Kariyawasam, N Zelyas, JN Kanji, MA Diggle |
Virology Journal | 2021 |
|
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
LM Meyers, AH Gutiérrez, CM Boyle, F Terry, BG McGonnigal, A Salazar, MF Princiotta, WD Martin, AS Groot, L Moise |
npj Vaccines | 2021 |
|
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection
RR Yuen, D Steiner, RM Pihl, E Chavez, A Olson, EL Smith, LA Baird, F Korkmaz, P Urick, M Sagar, JL Berrigan, S Gummuluru, RB Corley, K Quillen, AC Belkina, G Mostoslavsky, IR Rifkin, Y Kataria, AJ Cappione, W Gao, NH Lin, N Bhadelia, JE Snyder-Cappione |
Frontiers in immunology | 2021 |
|
Immunity to SARS-CoV-2: Lessons Learned
J Fergie, A Srivastava |
Frontiers in immunology | 2021 |
|
Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis
PX Du, YY Chou, HM Santos, BB Keskin, MH Hsieh, TS Ho, JY Wang, YL Lin, GD Syu |
Analytical Chemistry | 2021 |
|
COVID-19 Mechanisms in the Human Body—What We Know So Far
A Kumar, RK Narayan, P Prasoon, C Kumari, G Kaur, S Kumar, M Kulandhasamy, K Sesham, V Pareek, MA Faiq, SN Pandey, HN Singh, K Kant, PS Shekhawat, K Raza, S Kumar |
Frontiers in immunology | 2021 |
|
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses
E Marklund, S Leach, K Nyström, A Lundgren, JÅ Liljeqvist, S Nilsson, A Yilmaz, LM Andersson, M Bemark, M Gisslén |
Frontiers in immunology | 2021 |
|
The associations of previous influenza/upper respiratory infection with COVID-19 susceptibility/morbidity/mortality: a nationwide cohort study in South Korea
SY Kim, JH Kim, M Kim, JH Wee, Y Jung, C Min, DM Yoo, S Sim, HG Choi |
Scientific Reports | 2021 |
|
Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System
H Banoun |
Nephron. Clinical practice | 2021 |
|
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
K Röltgen, SD Boyd |
Cell Host & Microbe | 2021 |
|
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
KW Ng, N Faulkner, AG Wrobel, SJ Gamblin, G Kassiotis |
Seminars in Immunology | 2021 |
|
Humoral response to SARS‐CoV‐2 and seasonal coronaviruses in COVID‐19 patients
O Adams, M Andrée, D Rabl, PN Ostermann, H Schaal, E Lehnert, S Ackerstaff, L Müller, JC Fischer |
Journal of Medical Virology | 2021 |
|
Viral Coinfection is Associated with Improved Outcomes in Emergency Department Patients with SARS-CoV-2
E Goldberg, K Hasegawa, A Lawrence, J Kline, C Camargo |
Western Journal of Emergency Medicine | 2021 |
|
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
M Dugas, T Grote-Westrick, U Merle, M Fontenay, AE Kremer, F Hanses, R Vollenberg, E Lorentzen, S Tiwari-Heckler, J Duchemin, S Ellouze, M Vetter, J Fürst, P Schuster, T Brix, CM Denkinger, C Müller-Tidow, H Schmidt, PR Tepasse, J Kühn |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2021 |
|
Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
J Wang, C Guo, L Cai, C Liao, H Yi, Q Li, H Hu, Q Deng, Y Lu, Z Guo, Z Chen, J Lu |
Frontiers in immunology | 2021 |
|
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
R Borrega, DK Nelson, AP Koval, NG Bond, ML Heinrich, MM Rowland, R Lathigra, DJ Bush, I Aimukanova, WN Phinney, SA Koval, AR Hoffmann, AR Smither, AR Bell-Kareem, LI Melnik, KJ Genemaras, K Chao, P Snarski, AB Melton, JE Harrell, AA Smira, DH Elliott, JA Rouelle, G Sabino-Santos, AC Drouin, M Momoh, JD Sandi, A Goba, RJ Samuels, L Kanneh, M Gbakie, ZL Branco, JG Shaffer, JS Schieffelin, JE Robinson, DN Fusco, PC Sabeti, KG Andersen, DS Grant, ML Boisen, LM Branco, RF Garry |
Viruses | 2021 |
|
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease
G Fedele, G Russo, I Schiavoni, P Leone, E Olivetta, V Perri, MA Zingaropoli, MR Ciardi, P Pasculli, CM Mastroianni, P Stefanelli |
Diagnostic Microbiology and Infectious Disease | 2021 |
|
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests
I Montesinos, H Dahma, F Wolff, N Dauby, S Delaunoy, M Wuyts, C Detemmerman, C Duterme, O Vandenberg, C Martin, M Hallin |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2021 |
|
Application of Pandemic Intelligence in Dynamic Data in Taiwan
TY Chang, WR Su, H Chen, MW Huang, LY Chen |
International journal of environmental research and public health | 2021 |
|
Coronavirus Disease 2019 Mitigation Strategies Were Associated With Decreases in Other Respiratory Virus Infections
P Sinha, K Reifler, M Rossi, M Sagar |
Open Forum Infectious Diseases | 2021 |
|
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
CC Tan, CJ Owen, CY Tham, A Bertoletti, L van Dorp, F Balloux |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2021 |
|
Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19
K Inoue, S Kashima, AA Izzo |
PloS one | 2021 |
|
Ophthalmological Considerations for COVID-19 Vaccination in Patients with Inflammatory Eye Diseases and Autoimmune Disorders
CY Chau, LL Chow, S Sridhar, KC Shih |
Ophthalmology and Therapy | 2021 |
|
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
G Echeverría, Á Guevara, J Coloma, AM Ruiz, MM Vasquez, E Tejera, JH de Waard |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020
E Kissling, M Hooiveld, M Brytting, AM Vilcu, M Lange, I MartínezBaz, D Sigerson, T Enkirch, S Belhillil, A Meijer, J Castilla, N William, AS Carnahan, A Falchi, J Hendriksen, I Casado, J Murray, V Enouf, F Dijkstra, DF Marques, M Valenciano |
Influenza and Other Respiratory Viruses | 2021 |
|
Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19
WP Hausdorff, J Flores |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, C Pade, JM Gibbons, NL Bert, AT Tan, A Jeffery-Smith, CC Tan, CY Tham, S Kucykowicz, G Aidoo-Micah, J Rosenheim, J Davies, M Johnson, MP Jensen, G Joy, LE McCoy, AM Valdes, BM Chain, D Goldblatt, DM Altmann, RJ Boyton, C Manisty, TA Treibel, JC Moon, H Abbass, A Abiodun, M Alfarih, Z Alldis, M Andiapen, J Artico, JB Augusto, GL Baca, SN Bailey, AN Bhuva, A Boulter, R Bowles, RJ Boyton, OV Bracken, B OBrien, T Brooks, N Bullock, DK Butler, G Captur, N Champion, C Chan, D Collier, JC de Sousa, X Couto-Parada, T Cutino-Mogue, RH Davies, B Douglas, CD Genova, K Dieobi-Anene, A Ellis, K Feehan, M Finlay, M Fontana, N Forooghi, C Gaier, D Gilroy, M Hamblin, G Harker, J Hewson, LM Hickling, AD Hingorani, L Howes, A Hughes, G Hughes, R Hughes, I Itua, V Jardim, WY Lee, MP Jensen, J Jones, M Jones, G Joy, V Kapil, H Kurdi, J Lambourne, KM Lin, S Louth, V Mandadapu, Á McKnight, K Menacho, C Mfuko, O Mitchelmore, C Moon, D Munoz-Sandoval, SM Murray, M Noursadeghi, A Otter, S Palma, R Parker, K Patel, B Pawarova, SE Petersen, B Piniera, FP Pieper, D Pope, M Prossora, L Rannigan, A Rapala, CJ Reynolds, A Richards, M Robathan, G Sambile, A Semper, A Seraphim, M Simion, A Smit, M Sugimoto, S Taylor, N Temperton, S Thomas, GD Thornton, A Tucker, J Veerapen, M Vijayakumar, S Welch, T Wodehouse, L Wynne, D Zahedi, L van Dorp, F Balloux, Á McKnight, M Noursadeghi, A Bertoletti, MK Maini |
Nature | 2021 |
|
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
PR Wratil, NA Schmacke, B Karakoc, A Dulovic, D Junker, M Becker, U Rothbauer, A Osterman, PM Spaeth, A Ruhle, M Gapp, S Schneider, M Muenchhoff, JC Hellmuth, C Scherer, J Mayerle, M Reincke, J Behr, S Kääb, B Zwissler, M von Bergwelt-Baildon, J Eberle, L Kaderali, N Schneiderhan-Marra, V Hornung, OT Keppler |
Cell Reports | 2021 |
|
Knowledge into the Practice against COVID-19: A Cross-Sectional Study from Ghana
P Yeboah, DB Daliri, AY Abdin, E Appiah-Brempong, W Pitsch, AB Panyin, EB Adusei, A Razouk, MJ Nasim, C Jacob |
International journal of environmental research and public health | 2021 |
|
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response
CY Lin, J Wolf, DC Brice, Y Sun, M Locke, S Cherry, AH Castellaw, M Wehenkel, JC Crawford, VI Zarnitsyna, D Duque, KJ Allison, EK Allen, SA Brown, AH Mandarano, JH Estepp, C Taylor, C Molina-Paris, S Schultz-Cherry, L Tang, PG Thomas, MA McGargill, AH Gaur, JM Hoffman, T Mori, EI Tuomanen, RJ Webby, H Hakim, RT Hayden, DR Hijano, W Awad, R Bajracharya, BL Clark, V Cortez, RH Dallas, T Fabrizio, P Freiden, A Gowen, J Hodges, AM Kirk, EK Roubidoux, RC Mettelman, J Russell-Bell, A Souquette, J Sparks, LA de Velde, A Vazquez-Pagan, K Whitt, TL Wilson, DE Wittman, N Wohlgemuth, G Wu |
Cell Host & Microbe | 2021 |
|
Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
A Khanolkar |
Cells | 2021 |
|
The Pandemic Experience in Southeast Asia: Interface Between SARS-CoV-2, Malaria, and Dengue
C Yek, V Nam, R Leang, D Parker, S Heng, K Souv, S Sovannaroth, M Mayxay, S AbuBakar, R Sasmono, N Tran, H Nguyen, C Lon, K Boonnak, R Huy, L Sovann, J Manning |
2021 | |
|
Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals
Taira N, Toguchi S, Miyagi M, Mori T, Tomori H, Oshiro K, Tamai O, Kina M, Miyagi M, Tamaki K, Collins MK, Ishikawa H |
2021 | |
|
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Bertoletti A, Tan AT, Le Bert N |
2021 | |
|
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Loyal L, Braun J, Henze L, Kruse B, Dingeldey M, Reimer U, Kern F, Schwarz T, Mangold M, Unger C, Dörfler F, Kadler S, Rosowski J, Gürcan K, Uyar-Aydin Z, Frentsch M, Kurth F, Schnatbaum K, Eckey M, Hippenstiel S, Hocke A, Müller MA, Sawitzki B, Miltenyi S, Paul F, Mall MA, Wenschuh H, Voigt S, Drosten C, Lauster R, Lachman N, Sander LE, Corman VM, Röhmel J, Meyer-Arndt L, Thiel A, Giesecke-Thiel C |
Science (New York, N.Y.) | 2021 |
|
Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers.
da Silva Antunes R, Pallikkuth S, Williams E, Yu ED, Mateus J, Quiambao L, Wang E, Rawlings SA, Stadlbauer D, Jiang K, Amanat F, Arnold D, Andrews D, Fuego I, Dan JM, Grifoni A, Weiskopf D, Krammer F, Crotty S, Hoffer ME, Pahwa SG, Sette A |
medRxiv : the preprint server for health sciences | 2021 |
|
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike.
Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA, Wieland-Alter W, Lee J, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Wolf D, Goetghebuer T, Marchant A, Connor RI, Wright PF, Ackerman ME |
medRxiv : the preprint server for health sciences | 2021 |
|
Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity
Gouma S, Weirick ME, Bolton MJ, Arevalo CP, Goodwin EC, Anderson EM, McAllister CM, Christensen SR, Dunbar D, Fiore D, Brock A, Weaver J, Millar J, DerOhannessian S, Frank I, Rader DJ, Wherry EJ, Hensley SE |
2021 | |
|
Identification of resident memory CD8(+) T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue.
Niessl J, Sekine T, Lange J, Konya V, Forkel M, Maric J, Rao A, Mazzurana L, Kokkinou E, Weigel W, Llewellyn-Lacey S, Hodcroft EB, Karlsson AC, Fehrm J, Sundman J, Price DA, Mjösberg J, Friberg D, Buggert M |
Science Immunology | 2021 |
|
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
|
HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic
ER Simula, MA Manca, S Jasemi, S Uzzau, S Rubino, P Manchia, A Bitti, M Palermo, LA Sechi |
Microorganisms | 2020 |
|
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
EA Meyerowitz, P Sen, SR Schoenfeld, TG Neilan, MJ Frigault, JH Stone, AY Kim, MK Mansour |
Clinical Infectious Diseases | 2020 |
|
COVID-19—Lessons Learned and Questions Remaining
FC Fang, CA Benson, C del Rio, KM Edwards, VG Fowler, DN Fredricks, AP Limaye, BE Murray, S Naggie, PG Pappas, R Patel, DL Paterson, DA Pegues, WA Petri, RT Schooley |
Clinical Infectious Diseases | 2020 |
|
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, Gouma S, McAllister CM, Christensen SR, Weaver J, Hicks P, Manzoni TB, Oniyide O, Ramage H, Mathew D, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, D\u2019Andrea K, Kuthuru O, Dougherty J, Pattekar A, Kim J, Han N, Apostolidis SA, Huang AC, Vella LA, Wherry EJ, Meyer NJ, Cherry S, Bates P, Rader DJ, Hensley SE |
2020 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)